Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner
Molecules · 2024
DOI: 10.3390/molecules29215084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Kennedy R Wiens und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Pharmacology, Department of Biology, University of British Columbia Okanagan Campus, Kelowna, BC V1V 1V7, Canada. Hauptthemen laut MEDLINE: Microglia, Psilocybin. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council, Jack Brown and family Alzheimer Research Foundation, Jack Brown and Family Alzheimer’s Disease Research Foundation.
Abstract (Originalsprache)
Neuroinflammation that is caused by microglia, the main immune cells of the brain, contributes to neurodegenerative diseases. Psychedelics, including psilocybin and lysergic acid diethylamide (LSD), possess certain anti-inflammatory properties and, therefore, should be considered as drug candidates for treating neuroinflammatory pathologies. When ingested, psilocybin is rapidly dephosphorylated to yield psilocin, which crosses the blood–brain barrier and exerts psychotropic activity by interacting with the 5-hydroxytryptamine 2A receptors (5-HT2ARs) on neurons. Since microglia express all three 5-HT2R isoforms, we hypothesized that, by interacting with these receptors, psilocin beneficially modulates select neuroimmune functions of microglia. We used microglia-like cell lines to demonstrate that psilocin, at non-toxic concentrations, did not affect the secretion of tumor necrosis factor (TNF) by immune-stimulated microglial cells, but significantly inhibited their phagocytic activity, the release of reactive oxygen species (ROS), and nitric oxide (NO) production. The inhibitory activity of psilocin on the latter two functions was similar to that of two selective 5-HT2R agonists, namely, 25I-NBOH and Ro60-0175. The role of this subfamily of receptors was further demonstrated by the application of 5-HT2R antagonists cyproheptadine and risperidone. Psilocin should be considered a novel drug candidate that might be effective in treating neuroimmune disorders, such as neurodegenerative diseases, where reactive microglia are significant contributors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cellular and Molecular Pharmacology, Department of Biology, University of British Columbia Okanagan Campus, Kelowna, BC V1V 1V7, Canada.
ORCID-Profile: Bridget K Greuel, Andis Klegeris
Förderung
- Natural Sciences and Engineering Research Council
- Jack Brown and family Alzheimer Research Foundation
- Jack Brown and Family Alzheimer’s Disease Research Foundation
- Natural Sciences and Engineering Research Council of Canada
- University of British Columbia Okanagan Campus
Zitieren
APA
Wiens, K. R., Brooks, N. A. H., Riar, I., Greuel, B. K., Lindhout, I. A., & Klegeris, A. (2024). Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner. Molecules. https://doi.org/10.3390/molecules29215084
Vancouver
Wiens KR, Brooks NAH, Riar I, Greuel BK, Lindhout IA, Klegeris A. Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner. Molecules. 2024. doi:10.3390/molecules29215084
BibTeX
@article{Wiens2024,
author = {Wiens, Kennedy R and Brooks, Noah A H and Riar, Ishvin and Greuel, Bridget K and Lindhout, Ivan A and Klegeris, Andis},
title = {Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29215084}
}
EUVIMED